share_log

Innoviva Analyst Ratings

Benzinga Analyst Ratings ·  Oct 13, 2022 08:39
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/13/2022 8.11% Morgan Stanley $13 → $14 Maintains Underweight
08/08/2022 0.39% Morgan Stanley $12 → $13 Maintains Underweight
07/20/2022 23.55% Goldman Sachs → $16 Initiates Coverage On → Neutral
07/15/2022 -7.34% Morgan Stanley $13 → $12 Maintains Underweight
04/12/2022 0.39% Morgan Stanley $12 → $13 Maintains Underweight
02/23/2022 -7.34% Morgan Stanley $10 → $12 Maintains Underweight
02/11/2022 116.22% EF Hutton → $28 Initiates Coverage On → Buy
11/11/2020 -22.78% Morgan Stanley $8 → $10 Maintains Underweight
06/25/2018 Stifel Terminates Coverage On Hold → Hold
04/27/2018 23.55% Stifel $17 → $16 Maintains Hold
11/20/2017 0.39% Deutsche Bank → $13 Initiates Coverage On → Hold

Innoviva Questions & Answers

What is the target price for Innoviva (INVA)?

The latest price target for Innoviva (NASDAQ: INVA) was reported by Morgan Stanley on October 13, 2022. The analyst firm set a price target for $14.00 expecting INVA to rise to within 12 months (a possible 8.11% upside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Innoviva (INVA)?

The latest analyst rating for Innoviva (NASDAQ: INVA) was provided by Morgan Stanley, and Innoviva maintained their underweight rating.

When is the next analyst rating going to be posted or updated for Innoviva (INVA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Innoviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Innoviva was filed on October 13, 2022 so you should expect the next rating to be made available sometime around October 13, 2023.

Is the Analyst Rating Innoviva (INVA) correct?

While ratings are subjective and will change, the latest Innoviva (INVA) rating was a maintained with a price target of $13.00 to $14.00. The current price Innoviva (INVA) is trading at is $12.95, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment